# Augmented Vs. Normal Renal Replacement Therapy in Severe Acute Renal Failure (ARF).

> **NCT00221013** · PHASE4 · COMPLETED · sponsor: **The George Institute** · enrollment: 1508 (actual)

## Conditions studied

- Acute Renal Failure

## Interventions

- **PROCEDURE:** "augmented" CRRT regimen

## Key facts

- **NCT ID:** NCT00221013
- **Lead sponsor:** The George Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2008-10
- **Final completion:** 2009-01
- **Target enrollment:** 1508 (ACTUAL)
- **Last updated:** 2009-02-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00221013

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00221013, "Augmented Vs. Normal Renal Replacement Therapy in Severe Acute Renal Failure (ARF).". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00221013. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*